Public Sector Pension Investment Board (PSP Investments)’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-800,000
Closed -$2.45M 1434
2020
Q1
$2.45M Sell
800,000
-1,076,774
-57% -$4.41M 0.03% 542
2019
Q4
$9.65M Buy
1,876,774
+807,174
+75% +$4.1M 0.06% 309
2019
Q3
$5.52M Buy
1,069,600
+191,664
+22% +$1.07M 0.04% 497
2019
Q2
$5.31M Buy
877,936
+695,536
+381% +$4.88M 0.04% 410
2019
Q1
$1.32M Buy
182,400
+95,600
+110% +$691K 0.01% 927
2018
Q4
$642K Buy
+86,800
New +$550K 0.01% 1182

Other funds holding PACB

Public Sector Pension Investment Board (PSP Investments)'s PACB Position: Q2 2020 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Pacific Biosciences (PACB) in Q2 2020, closing a stake of 800,000 shares — an estimated $2.45M sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in PACB in Q4 2018 and held it in 6 quarters. The position peaked at $9.65M in Q4 2019. 151 funds tracked by Wall St. Rank hold PACB as of Q2 2020.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Pacific Biosciences position as of Q2 2020 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 800,000 Pacific Biosciences shares in Q2 2020, an estimated $2.45M.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Pacific Biosciences in Q4 2018 and held it in 6 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Pacific Biosciences position peaked at $9.65M in Q4 2019.
  • 151 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2020.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2020, filed 14 Aug 2020.